Advertisement
Screener

PUMA BIOTECHNOLOGY, INC. (PBYI) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number

2.1 / 5 stars · 34/80 Roast Me

PUMA BIOTECHNOLOGY, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number

PUMA BIOTECHNOLOGY, INC. (PBYI) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 9.47 thousand shares as of 2016-06-30, per its 10-Q filed 2016-08-09.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2016-08-09

  • 2016-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 9.47K shares.
  • 2016-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 9.47K shares.
  • 2015-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 9.47K shares.
  • 2015-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 18.94K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
2016-06-309.47K shares
10-Q · filed 2016-08-09
2016-03-319.47K shares
10-Q · filed 2016-05-10
2015-12-319.47K shares
10-Q · filed 2016-08-09
2015-09-3018.94K shares
10-Q · filed 2015-11-09
2015-06-3018.94K shares
10-Q · filed 2015-08-10
2015-03-3118.94K shares
10-Q · filed 2015-05-11
2014-12-3118.94K shares
10-K · filed 2016-02-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
ARVINAS, INC. (ARVN)United States$0.510B58.38
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
Evolus, Inc. (EOLS)United States$0.519B-13.32
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76